Lebrikizumab Antibody
Lebrikizumab is a humanized monoclonal antibody designed to selectively inhibit interleukin-13 (IL-13), a key driver of Th2-mediated inflammation. It is extensively utilized in preclinical and clinical research for asthma and atopic dermatitis, supporting both in vitro mechanistic studies and in vivo disease model investigations.
Product Specifications
Product Name Alternative
RG 3637, RO 5490255, RO5490255, TNX650, TNX-650, LY 3650150
Target
Interleukin, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
6.85 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.27 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS026140-20ug 20 µg
TTLL3 (NM_001025930) Human Over-expression Lysate
Sign In for Pricing
View Details